What is CorMedix's EBITDA margin?

CorMedix (CRMD) reported EBITDA margin of 54.6% in Q1 2026.

What is the long-term trend for CorMedix's EBITDA margin?

Over 3 years (2020 to 2025), CorMedix's EBITDA margin has grown at a -83.3% compound annual growth rate (CAGR), from -11,324.9% to 52.8%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

CorMedix CRMD EBITDA margin

EBITDA margin at other companies

PfizerPFE

25.3%—

Merck & Co.MRK

22.4%-12.4pp

Merit Medical SystemsMMSI

20.2%+0.9pp

ITG

Integer HoldingsITGR

18.3%-0.8pp

IAR

Integra LifeSciencesIART

-19.5%-30.1pp

Emergent BiosolutionsEBS

27.5%+25.2pp

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

ebitda/total revenue=54.6%

Based on trailing twelve months.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's EBITDA margin?: CorMedix (CRMD) reported EBITDA margin of 54.6% in Q1 2026.
What is the long-term trend for CorMedix's EBITDA margin?: Over 3 years (2020 to 2025), CorMedix's EBITDA margin has grown at a -83.3% compound annual growth rate (CAGR), from -11,324.9% to 52.8%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.